- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Employers choose to retain drug coverage for retirees
Washington, d.c.—The advent of Medicare prescription drug coverage for seniors is not prompting large employers to abandon retiree drug benefits, at least not for this year. Most large businesses are accepting federal government subsidies for retiree drug coverage in 2006, although there are signs that this could change over the next five years.
WASHINGTON, D.C.-The advent of Medicare prescription drug coverage for seniors is not prompting large employers to abandon retiree drug benefits, at least not for this year. Most large businesses are accepting federal government subsidies for retiree drug coverage in 2006, although there are signs that this could change over the next five years.
Almost 80% of large employers decided to accept a 28% tax-free subsidy on outlays for retiree drug benefits in return for continuing coverage, according to a survey by Hewitt Associates and the Kaiser Family Foundation. Although an alternative "supplement" approach appears to offer even more savings to companies, employers opted for the subsidy as the least disruptive move at a time of considerable uncertainty about how the new Medicare drug benefit will work. Most employers say they are likely to stay with the subsidy plan next year, but about half say they may change by 2010.
EMPLOYER SUBSIDIES
While employers continue to reassess options for retiree drug coverage, they are taking steps to contain costs overall on retiree benefits. Companies are boosting retiree premiums, copayments and annual deductibles; nearly two-thirds have placed caps on future financial obligations for retiree coverage. At the same time, a small number (19%) of employers have limited the amount that retirees have to pay themselves by boosting annual out-of-pocket maximums.
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More
